Online citations, reference lists, and bibliographies.

Antidepressant Medications: A Review Of The Evidence For Drug-induced Sexual Dysfunction.

Stuart A. Montgomery, David S. Baldwin, Anne W. Riley
Published 2002 · Psychology, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Sexual dysfunction is recognised as a potential side effect of antidepressant therapy. However, there is little detailed information on the prevalence of drug-induced sexual dysfunction or the differences, if any, between available drugs. This article is a critical review of the literature in the area. METHODS English-language studies on sexual dysfunction and depression or antidepressant treatments were identified by searching Medline and supplemented by manual review of their reference lists and recent journal issues available in a library. Trials of antidepressant use in anxiety disorders were identified from a Medline search and their adverse events tables scanned for data on sexual dysfunction. All trials were assessed according to predefined criteria. RESULTS Sexual dysfunction is widespread in the healthy non-depressed population and is a recognised symptom of depression and/or anxiety disorders. Sexual dysfunction has been reported with all classes of antidepressants (MAOIs, TCAs, SSRIs, SNRIs and newer antidepressants) in patients with depression and various anxiety disorders. Numerous studies have been published, but only one used a validated sexual function rating scale and most lacked either a baseline or a placebo control or both. None met all of the pre-defined assessment criteria. LIMITATIONS The search techniques may have missed some studies and publication bias cannot be ruled out. CONCLUSIONS The existing literature confirms sexual dysfunction as a possible adverse event of all antidepressants, but it is not sufficiently robust to support claims for differences in the incidence of drug-induced sexual dysfunctions between existing antidepressant therapies. Prescribing decisions should be based on a careful assessment of the benefits and risks of therapy in the individual patient.



This paper is referenced by
05 ST 012 BA XP
Ján Praško (2004)
10.1177/0269881107083798
Review: Bupropion and SSRI-induced side effects
Koen Demyttenaere (2008)
10.1080/15622970701227829
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care
Michael Bauer (2007)
10.1177/0269881109351966
Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study
Mohammad Reza Safarinejad (2011)
10.1016/j.ejmech.2010.12.018
Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors.
Susanna Nencetti (2011)
10.1016/B978-0-323-41559-0.00016-2
Chapter 16 – Neurologic Aspects of Sexual Function
David Myland Kaufman (2017)
10.1017/S0790966700012192
Sexual dysfunction and antidepressants: a review with emphasis on treatment.
Maeve Kenny (2011)
Tratamiento antidepresivo y el funcionamiento del generador espinal de la eyaculación
María Eugenia Hueletl-Soto (2011)
10.1155/2018/3093516
Huanglian-Wendan Decoction Inhibits NF-κB/NLRP3 Inflammasome Activation in Liver and Brain of Rats Exposed to Chronic Unpredictable Mild Stress
Ke-Ke Jia (2018)
10.1300/J074v19n01_09
Sexual Problems, Women and Aging: An Overview
Victor J. Malatesta (2007)
10.1016/j.phymed.2010.02.010
Griffonia simplicifolia negatively affects sexual behavior in female rats.
Gianluca Carnevale (2010)
World Psychiatryis indexed in PubMed, Current Contents/Clinical Medicine, Current Contents/Social and Behavioral Sciences, Science Citation Index, and EMBASE Âñåìèðíàÿ Ïñèõèàòðè÷åñêàÿ Àññîöèàöèÿ (ÂÏÀ)
Mario Maj (2011)
10.4103/0253-7176.191379
Sexual Dysfunction among Females Receiving Psychotropic Medication: A Hospital-based Cross-sectional Study
Veda N. Shetageri (2016)
10.1097/JCP.0b013e318172b48c
A Double-Blind Comparison of Sexual Functioning, Antidepressant Efficacy, and Tolerability Between Agomelatine and Venlafaxine XR
Sidney H. Kennedy (2008)
10.1007/s40264-013-0069-z
Reports of Sexual Disorders Related to Serotonin Reuptake Inhibitors in the French Pharmacovigilance Database: An Example of Underreporting
Thierry Trenque (2013)
10.1111/j.1743-6109.2010.01903.x
Biochemical factors modulating female genital sexual arousal physiology.
Abdulmaged M Traish (2010)
10.18632/oncotarget.10727
Long-term administration of ketamine induces erectile dysfunction by decreasing neuronal nitric oxide synthase on cavernous nerve and increasing corporal smooth muscle cell apoptosis in rats
Hung-Sheng Shang (2017)
10.3922/j.psns.2009.1.10
Sexual experience did not affect the long-term sexual behavior inhibition of male rats treated with fluoxetine
Soraya Ferreira Habr (2009)
10.5455/jmood.20180219113932
Spontaneous Erection and Ejaculation Caused by Escitalopram
Betul Hande Gursoy (2018)
IMMUNOLOCALIZATION OF SEROTONERGIC NEURONS DURING NATURAL SEX CHANGE IN THE HERMAPHRODITIC GOBY LYTHRYPNUS DALLI
(2010)
Effect on sexual dysfunction in depressed females after treatment with SSRI
S Sawant Neena (2014)
10.3109/13651501.2011.590209
Treatment-emergent sexual dysfunction with SSRIs and duloxetine: Effectiveness and functional outcomes over a 6-month observational period
Héctor José Dueñas (2011)
10.1016/B978-0-7234-3748-2.00016-5
Chapter 16 – Neurologic Aspects of Sexual Function
David Myland Kaufman (2013)
10.3389/fnmol.2018.00056
Clinical Findings Documenting Cellular and Molecular Abnormalities of Glia in Depressive Disorders
Boldizsár Czéh (2018)
10.1016/j.jsxm.2016.02.172
The Physiology of Female Sexual Function and the Pathophysiology of Female Sexual Dysfunction (Committee 13A).
Roy J Levin (2016)
10.1517/14740338.2014.951324
Sexual dysfunction associated with major depressive disorder and antidepressant treatment
Anita H. Clayton (2014)
10.1080/15622970801981606
Outcomes in major depressive disorder: The evolving concept of remission and its implications for treatment
H J Möller (2008)
10.1038/mp.2015.53
Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression
Fredrik Hieronymus (2016)
10.1016/j.psc.2016.04.006
Sexual Dysfunction Due to Psychotropic Medications.
Anita H. Clayton (2016)
10.14288/1.0066984
The endocannabinoid system as a novel target in the pathophysiology and treatment of depressive illness
Matthew Nicholas Hill (2008)
10.1002/9781119266136.CH9
Psychological Management of Arousal Disorders
Isbelia Segnini (2018)
10.1111/j.1743-6109.2012.02762.x
SIEDY scale 3, a new instrument to detect psychological component in subjects with erectile dysfunction.
Giovanni Corona (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar